We are live on
!
Find out more
Baird Financial Group Portfolio holdings
AUM
$64B
1-Year Est. Return
22.64%
This Fund
S&P 500
This Quarter
Est. Return
+1.53%
1 Year Est. Return
+22.64%
3 Year Est. Return
+71.5%
5 Year Est. Return
+89.73%
10 Year Est. Return
+347.75%
AUM
$48.2B
AUM Growth
+$517M
(+1.1%)
Cap. Flow
+$459M
Cap. Flow
% of AUM
0.95%
Top 10 Holdings %
Top 10 Hldgs %
23.88%
Holding
1,852
New
102
Increased
811
Reduced
727
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$225M |
| 2 |
CarMax
KMX
|
+$71.7M |
| 3 |
Zebra Technologies
ZBRA
|
+$54.1M |
| 4 |
Raymond James Financial
RJF
|
+$52.9M |
| 5 |
Meta Platforms (Facebook)
META
|
+$49.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$91.5M |
| 2 |
RBC Bearings
RBC
|
+$83.2M |
| 3 |
Align Technology
ALGN
|
+$68.4M |
| 4 |
GE Aerospace
GE
|
+$60.9M |
| 5 |
JB Hunt Transport Services
JBHT
|
+$54.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.05% |
| 2 | Financials | 12.75% |
| 3 | Industrials | 10.15% |
| 4 | Consumer Discretionary | 8.15% |
| 5 | Healthcare | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Invesco Municipal Income Opportunities Trust
OIA
$292M
| $79.7K | ﹤0.01% |
12,555
-40,379
| -76% | -$253K |
|
1727
QuantumScape Corp
QS
$3.14B
| $78.9K | ﹤0.01% |
16,035
-2,300
| -13% | -$12.8K |
|
1728
SiriusXM
SIRI
$10.6B
| $77.2K | ﹤0.01% |
2,728
-113
| -4% | -$3.38K |
|
1729
Lucid Motors
LCID
$2.86B
| $73.4K | ﹤0.01% |
2,813
-1,580
| -36% | -$42.2K |
|
|
BLUE
1730
DELISTED
bluebird bio
BLUE
| $61.3K | ﹤0.01% |
3,113
+2,488
| +398% | +$49.8K |
|
1731
Catheter Precision
VTAK
$1.05M
| $58.8K | ﹤0.01% |
529
| – | – |
|
1732
Kosmos Energy
KOS
$1.39B
| $55.4K | ﹤0.01% |
+10,000
| New | +$58.3K |
|
1733
OmniAb
OABI
$288M
| $54.7K | ﹤0.01% |
14,580
-170
| -1% | -$775 |
|
1734
OPAL Fuels
OPAL
$67.7M
| $54.2K | ﹤0.01% |
13,249
| – | – |
|
1735
Geron
GERN
$943M
| $48.8K | ﹤0.01% |
+11,500
| New | +$44.8K |
|
1736
ChargePoint
CHPT
$137M
| $42.3K | ﹤0.01% |
1,401
-168
| -11% | -$5.47K |
|
|
CYPH
1737
Cypherpunk Technologies Inc
CYPH
$66M
| $41.9K | ﹤0.01% |
+21,400
| New | +$56.1K |
|
1738
Nordic American Tanker
NAT
$1.36B
| $39.8K | ﹤0.01% |
+10,000
| New | +$40.2K |
|
1739
Cognition Therapeutics
CGTX
$82.1M
| $37.2K | ﹤0.01% |
22,393
| – | – |
|
1740
B2Gold
BTG
$5.12B
| $33.8K | ﹤0.01% |
12,500
-12,300
| -50% | -$33.2K |
|
1741
Karyopharm Therapeutics
KPTI
$157M
| $31.9K | ﹤0.01% |
2,453
+1,066
| +77% | +$17.6K |
|
1742
Lumen
LUMN
$6.22B
| $30.6K | ﹤0.01% |
27,786
-13,126
| -32% | -$16.6K |
|
|
CLLS
1743
Cellectis
CLLS
$285M
| $28.2K | ﹤0.01% |
+15,090
| New | +$39.6K |
|
1744
Globalstar
GSAT
$10.2B
| $28K | ﹤0.01% |
1,667
| – | – |
|
|
WBX
1745
Wallbox
WBX
$85.1M
| $25.8K | ﹤0.01% |
986
-14
| -1% | -$406 |
|
|
NGD
1746
DELISTED
New Gold Inc
NGD
| $22.4K | ﹤0.01% |
11,500
| – | – |
|
1747
Cerus
CERS
$589M
| $21K | ﹤0.01% |
11,950
| – | – |
|
|
FLDDW
1748
Fold Holdings Warrant
FLDDW
$995K
| $18K | ﹤0.01% |
400,994
| – | – |
|
1749
Akebia Therapeutics
AKBA
$335M
| $17.7K | ﹤0.01% |
17,393
+1,650
| +10% | +$2.04K |
|
|
TELL
1750
DELISTED
Tellurian Inc.
TELL
| $13.7K | ﹤0.01% |
19,762
| – | – |
|
Similar funds
Baird Financial Group's Q2 2024 Portfolio in Review
As of Q2 2024, Baird Financial Group held 1,852 positions worth $48.2B, up 1.1% from $47.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Baird Financial Group's Q2 2024 filing shows 102 new, 811 increased, 727 reduced and 99 closed positions. Its largest new stake was GE Vernova: 1,419,167 shares worth $243M. The largest sale was Pfizer, an estimated $91.5M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Baird Financial Group's largest Q2 2024 buy was GE Vernova: 1,419,167 shares worth $243M.
- Baird Financial Group added most to CarMax in Q2 2024, an estimated $71.7M increase.
- Baird Financial Group's biggest Q2 2024 reduction was Pfizer, cutting an estimated $91.5M.
- Baird Financial Group fully exited RBC Bearings in Q2 2024, selling an estimated $83.2M.
- Baird Financial Group's ten largest holdings make up 24% of its $48.2B portfolio in Q2 2024.
- Baird Financial Group opened 102 new positions and closed 99 in Q2 2024.
- Baird Financial Group's portfolio value rose 1.1% quarter-over-quarter to $48.2B.
Based on Baird Financial Group's 13F filing for Q2 2024, filed 14 Aug 2024.